Business Context and Reporting Period
This Form 8-K Current Report was filed by Workhorse Group Inc. on February 19, 2019, regarding events occurring on February 18, 2019. The filing discloses the appointment of a new executive officer and the associated compensatory arrangements.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation details:
- Base Salary: $250,000 per year.
- Target Performance Bonus: 50% of base salary, with potential to increase to 100% or 150% based on milestones.
- Equity Grant: Option to purchase 400,000 shares of common stock, subject to shareholder approval of the 2019 Stock Incentive Plan.
- Vesting Schedule: Four-year vesting period in equal quarterly installments.
Material Changes
The primary material change is the appointment of Robert Willison as Chief Operating Officer, effective February 18, 2019. Mr. Willison previously served as the Company's Director of Research and Development from 2016 to 2018 and most recently as Director of Fleet Technology for Sysco Corporation.
Outlook, Risks, and Contingencies
Compensation Contingencies: The equity grant is contingent upon shareholder approval of the 2019 Stock Incentive Plan. The exercise price will equal the closing stock price on the date of approval.
Severance Provisions: In the event of termination without cause or resignation for good reason, Mr. Willison is entitled to severance equal to his base salary plus a prorated target bonus. Additionally, all outstanding equity awards would immediately accelerate and vest, and the Company would cover COBRA premiums for up to twelve months. These benefits also apply if such termination occurs within twelve months following a change in control.
Investor Verification Checklist
- Verify the status of the shareholder vote for the 2019 Stock Incentive Plan to confirm the issuance of the 400,000 stock options.
- Review the full text of the Retention Agreement (Exhibit 10.1) for specific definitions of "good reason" and "change in control."
- Confirm the closing stock price on the date of shareholder approval to determine the option exercise price.
- Assess the impact of the accelerated vesting provisions on potential future dilution in a change of control scenario.